| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |